BG62066B2 - (s)-(-)-1-пропил-2',6'-пипеколоксилидидов хидрохлорид монохидрат, метод за получаването му и фармацевтичен препарат, който го съдържа - Google Patents

(s)-(-)-1-пропил-2',6'-пипеколоксилидидов хидрохлорид монохидрат, метод за получаването му и фармацевтичен препарат, който го съдържа Download PDF

Info

Publication number
BG62066B2
BG62066B2 BG098494A BG9849494A BG62066B2 BG 62066 B2 BG62066 B2 BG 62066B2 BG 098494 A BG098494 A BG 098494A BG 9849494 A BG9849494 A BG 9849494A BG 62066 B2 BG62066 B2 BG 62066B2
Authority
BG
Bulgaria
Prior art keywords
propyl
water
compound
added
acetone
Prior art date
Application number
BG098494A
Other languages
Bulgarian (bg)
English (en)
Inventor
Rune Sandberg
Original Assignee
Astra Laekemedel Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20363001&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG62066(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Laekemedel Aktiebolag filed Critical Astra Laekemedel Aktiebolag
Publication of BG62066B2 publication Critical patent/BG62066B2/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG098494A 1986-01-03 1994-02-18 (s)-(-)-1-пропил-2',6'-пипеколоксилидидов хидрохлорид монохидрат, метод за получаването му и фармацевтичен препарат, който го съдържа BG62066B2 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8600017A SE451840B (sv) 1986-01-03 1986-01-03 Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning

Publications (1)

Publication Number Publication Date
BG62066B2 true BG62066B2 (bg) 1999-01-29

Family

ID=20363001

Family Applications (1)

Application Number Title Priority Date Filing Date
BG098494A BG62066B2 (bg) 1986-01-03 1994-02-18 (s)-(-)-1-пропил-2',6'-пипеколоксилидидов хидрохлорид монохидрат, метод за получаването му и фармацевтичен препарат, който го съдържа

Country Status (29)

Country Link
US (1) US4870086A (da)
EP (1) EP0239710B1 (da)
JP (1) JPH07598B2 (da)
KR (1) KR940008302B1 (da)
AR (1) AR242561A1 (da)
AT (1) ATE56956T1 (da)
AU (1) AU592392B2 (da)
BG (1) BG62066B2 (da)
CA (1) CA1276154C (da)
CY (1) CY1680A (da)
DE (1) DE3674582D1 (da)
DK (1) DK171378B1 (da)
EG (1) EG17867A (da)
ES (1) ES2036179T3 (da)
FI (1) FI83075C (da)
GR (1) GR3002516T3 (da)
HK (1) HK5493A (da)
IE (1) IE59061B1 (da)
LU (1) LU88843I2 (da)
LV (1) LV5765B4 (da)
MY (1) MY101132A (da)
NL (1) NL960005I2 (da)
NO (2) NO170330C (da)
NZ (1) NZ218615A (da)
PH (1) PH22924A (da)
PT (1) PT84041B (da)
SE (1) SE451840B (da)
SG (1) SG117292G (da)
ZA (1) ZA868600B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT97888B (pt) * 1990-06-07 1998-12-31 Zeneca Ltd Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem
US5834490A (en) * 1993-11-04 1998-11-10 Instituto De Investigacion Y Desarrolo Quimico Biologico, S.A. Cyclopropyl derivatives, preparation method there-of and applications
ES2082703B1 (es) * 1993-11-04 1996-12-16 Inst Investigacion Desarrollo Nuevos derivados de ciclopropilo, procedimientos para su preparacion y aplicaciones.
ATE214695T1 (de) * 1994-09-23 2002-04-15 Darwin Discovery Ltd Racemisierungsverfahren bei der herstellung von levobupivacaine und analogen
SE9501808D0 (sv) * 1995-05-16 1995-05-16 Astra Ab New process
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
SE9800139D0 (sv) 1998-01-21 1998-01-21 Astra Ab New use
BRPI0104491B8 (pt) * 2001-10-10 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica.
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
US7683175B2 (en) * 2005-06-06 2010-03-23 Navinta, Llc Process of making optically pure L-pipecolic acid and process of making anesthetics and intermediates therefrom
WO2007123405A1 (en) * 2006-04-25 2007-11-01 Dishman Pharmaceuticals And Chemicals Ltd. Ropivacaine hydrochloride anhydrate and the preparation thereof
PL2234974T3 (pl) * 2008-01-15 2012-09-28 Pharmathen Sa Sposób otrzymywania związku (s)-1-alkilo-2', 6'-pipekoloksylidydu
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
CN102093284B (zh) * 2010-12-29 2013-05-08 宜昌人福药业有限责任公司 富集哌啶-2-甲酰苯胺类旋光化合物的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2248018A (en) * 1939-03-30 1941-07-01 Winthrop Chem Co Inc 4-aryl-piperidine-ketones and a process of preparing them
GB775749A (en) * 1955-04-06 1957-05-29 Bofors Ab Method of preparing amides of n-alkyl piperidine monocarboxylic acid and n-alkyl pyrrolidine -a-monocarboxylic acid
GB775750A (en) * 1955-04-28 1957-05-29 Bofors Ab Method of preparing amides of n-alkyl piperidine mono-carboxylic acid and n-alkyl pyrrolidine -a-monocarboxylic acid
US2799679A (en) * 1955-04-28 1957-07-16 Bofors Ab Process of preparing amides of heterocyclic carboxylic acids
GB800565A (en) * 1956-01-23 1958-08-27 Bofors Ab Method of producing n-alkyl-piperidine-ª‡-monocarboxylic acid amides and n-alkyl-pyrrolidine-ª‡-monocarboxylic acid amides
GB824542A (en) * 1957-05-15 1959-12-02 Bofors Ab Method of producing n-alkyl-piperidine-alpha-monocarboxylic acid amides
GB869978A (en) * 1958-03-13 1961-06-07 Bofors Ab Method of producing n-alkyl-and-cycloalkyl-piperidine carboxylic acid amides
GB949729A (en) * 1960-11-15 1964-02-19 Bofors Ab Substituted-piperidine carboxylic acid amide salts and their preparation
SE341404B (da) * 1967-05-18 1971-12-27 Sterling Drug Inc
CH491915A (de) * 1967-06-28 1970-06-15 Geigy Ag J R Verfahren zur Herstellung von neuen Piperidinderivaten
US3879382A (en) * 1971-08-27 1975-04-22 Teijin Ltd Process for the recovery of D- or L-{60 -amino-{68 -caprolactam hydrochloride of enhanced optical purity from mixtures of D- and L-{60 -amino-{68 -caprolactam hydrochloride
SE7607114L (sv) * 1976-06-22 1977-12-23 Bofors Ab Sett att framstella hydrokloriden av n-metylpiperidin-2-karbonsyra-2,6-xyllidid
SE431092B (sv) * 1979-07-10 1984-01-16 Thuresson Af Ekenstam Bo Terapeutiskt aktiva, substituerade piperidinkarboxianilider
EP0151110B1 (en) * 1983-08-01 1989-03-01 Astra Läkemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same

Also Published As

Publication number Publication date
NL960005I2 (nl) 1997-10-01
PH22924A (en) 1989-01-24
FI870003A0 (fi) 1987-01-02
DE3674582D1 (de) 1990-10-31
GR3002516T3 (en) 1993-01-25
NO864858D0 (no) 1986-12-03
NO170330B (no) 1992-06-29
ES2036179T3 (es) 1993-05-16
CA1276154C (en) 1990-11-13
MY101132A (en) 1991-07-31
FI870003L (fi) 1987-07-04
KR870007118A (ko) 1987-08-14
ZA868600B (en) 1987-08-26
FI83075C (fi) 1991-05-27
IE870004L (en) 1987-07-03
AR242561A1 (es) 1993-04-30
LV5765B4 (lv) 1997-06-20
NL960005I1 (nl) 1996-09-02
PT84041A (en) 1987-01-01
HK5493A (en) 1993-01-29
DK287A (da) 1987-07-04
PT84041B (pt) 1989-09-14
SE8600017D0 (sv) 1986-01-03
NO1997009I1 (no) 1997-08-18
EG17867A (en) 1991-03-30
DK171378B1 (da) 1996-10-07
LU88843I2 (fr) 1997-03-14
JPH07598B2 (ja) 1995-01-11
JPS62158251A (ja) 1987-07-14
DK287D0 (da) 1987-01-02
SG117292G (en) 1993-01-29
US4870086A (en) 1989-09-26
FI83075B (fi) 1991-02-15
AU6644986A (en) 1987-07-09
ATE56956T1 (de) 1990-10-15
AU592392B2 (en) 1990-01-11
EP0239710B1 (en) 1990-09-26
KR940008302B1 (ko) 1994-09-12
NO864858L (no) 1987-07-06
CY1680A (en) 1993-10-10
LV5765A4 (lv) 1996-12-20
SE451840B (sv) 1987-11-02
NZ218615A (en) 1989-07-27
NO170330C (no) 1992-10-07
IE59061B1 (en) 1993-12-15
SE8600017L (sv) 1987-07-04
EP0239710A1 (en) 1987-10-07

Similar Documents

Publication Publication Date Title
BG62066B2 (bg) (s)-(-)-1-пропил-2',6'-пипеколоксилидидов хидрохлорид монохидрат, метод за получаването му и фармацевтичен препарат, който го съдържа
RU2720677C1 (ru) Соединение, представляющее собой пролекарство ланостерина, а также способ его получения и его применение
SU1272992A3 (ru) Способ получени 9-(3,4-диоксибутил)-гуанина
RU2128160C1 (ru) Трометаминная соль (+)-(s)-2-(3-бензоилфенил)пропионовой кислоты, способ ее получения, фармацевтическая композиция
EP0755398B1 (en) Process for the resolution of etodolac using glucamine derivatives
KR910004599A (ko) 1,3-디하이드로-1-(피리디닐아미노)-2h-인돌-2-온, 이들의 제조방법 및 이들의 약제로서의 용도
JP2003535885A (ja) 制御された範囲内にｐＨを持つ安定なギャバペンチン
US5412095A (en) Terazosin monohydrochloride and processes and intermediate for its production
JPS6051172A (ja) ピロリジノン誘導体
US4472387A (en) Pharmaceutical compositions capable of increasing cerebral serotonin concentration
BG60797B2 (bg) Сол на(1-бензил-1н-индазол-3-ил)оксиоцетна киселина с лизин и метод за получаването й
US2776993A (en) 1-paramethoxyphenyl-2-cyclopentylamino-1-propanol compounds
US4189499A (en) Lysine 4-allyloxy-3-chlorophenylacetate and method of its preparation
SI8711067A8 (en) Process for obtaining monohydrate of optically pure s-(-)-1 propyl-2',6' pipecoloxylidid chlorinehydrate
CN87104296A (zh) 一种旋光纯化合物和其制备方法
CN113801120B (zh) Mdm2抑制剂的微悬浮液以及治疗应用
SU1447283A3 (ru) Способ получени конденсированных производных @ S-триазина
CN101142200A (zh) 甲苯哌丙酮的加成盐，其制备方法和其用途
JPS59176260A (ja) ８−アミノ−２−メチル−４−フエニル−１，２，３，４−テトラヒドロイソキノリンの光学対掌体
US3519638A (en) 4,5-diphenylimidazole derivative
HU198689B (en) Process for producing optically pure s-/-/-1-propyl-2'6'-pipekoloxilidiol-gidrokhloride-monohydrate and pharmaceutical compositions containing them
BG63046B1 (bg) Пиролидинилметилиндолова сол
PL150293B1 (pl) spo sOb wytwarzania praktycznie optycznie czystego jednowodzianu chlorowodorku 2,6-DWUMETYLOANILIDU KWASU S-/-/-1-PROPYLOPIPEKOLINOWEGO
JPS63225343A (ja) ドブタミン塩の改良
JPS6072848A (ja) Ｌまたは（ｓ）−３−（３．４−ジヒドロキシフエニル）−２−メチルアラニンエステルの結晶性塩およびその製法